Health needs, drug registration and control in less developed countries - The Peruvian case

Albert Figueras, Susana Vasquez, Josep Maria Arnau, Joan Ramon Laporte

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

Abstract

A number of factors influence how medicines are used in each community, but drug registration is the initial and usually necessary step. In the course of an external advisory consultation, the list of approved medicines in Peru in 1998 was examined. Of 1672 newly approved forms, 119 were of 49 new chemical entities. Sildenafil, meloxicam, nimesulide, candesartan, irebesartan, naratriptan, trovafloxacin and grepafloxacin were among them. Several aspects about the new global drug situation and 'real' health needs versus 'induced' health needs are discussed from this example. Copyright © 2002 John Wiley & Sons, Ltd.
Original languageEnglish
Pages (from-to)63-64
JournalPharmacoepidemiology and Drug Safety
Volume11
Issue number1
DOIs
Publication statusPublished - 13 Apr 2002

Fingerprint

Dive into the research topics of 'Health needs, drug registration and control in less developed countries - The Peruvian case'. Together they form a unique fingerprint.

Cite this